Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy.
about
Cardiotonic Steroids as Modulators of NeuroinflammationMyeloid Extracellular Vesicles: Messengers from the Demented BrainClearance systems in the brain-implications for Alzheimer diseaseThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanismsOxidized cholesterol as the driving force behind the development of Alzheimer's diseaseInflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical diseaseTherapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 alleleNeuroimmune mechanisms of depressionNeuroinflammation in Alzheimer's diseaseMechanisms of mononuclear phagocyte recruitment in Alzheimer's diseaseThe crustacean central nervous system in focus: subacute neurodegeneration induces a specific innate immune responseLRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.How Do Meningeal Lymphatic Vessels Drain the CNS?Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension.Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease.Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process.Ontogeny and functions of central nervous system macrophages.Vascular and metabolic dysfunction in Alzheimer's disease: a review.High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's diseaseApolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 miceScavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse modelVascular basement membranes as pathways for the passage of fluid into and out of the brain.The promotion of functional urinary bladder regeneration using anti-inflammatory nanofibersHow to get from here to there: macrophage recruitment in Alzheimer's diseaseMaternal immune activation leads to activated inflammatory macrophages in offspringDifferential role of CCR2 in the dynamics of microglia and perivascular macrophages during prion diseaseImmunotherapy of cerebrovascular amyloidosis in a transgenic mouse modelAtherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureHigh levels of homocysteine results in cerebral amyloid angiopathy in miceExpression of the mannose receptor CD206 in HIV and SIV encephalitis: a phenotypic switch of brain perivascular macrophages with virus infection.Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer's disease.Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses.Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse modelPlatelets in the Alzheimer's disease brain: do they play a role in cerebral amyloid angiopathy?Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
P2860
Q26766722-0D4AF7D6-0FA8-4D76-99E2-B3E83A5C871EQ26767455-EF8B79FF-DD0D-47B7-B28E-59539CF084D8Q26801541-6FB31CA4-3CC2-4678-ACF0-B76C206E4193Q26861263-C9B5F36B-2DC3-47DC-99B4-DE237077D5ABQ27001177-2E3BC48C-0AD7-49E9-85CC-9445277127B0Q27023315-1DFBD7E5-DD8F-4D32-B8BE-5935840F55FCQ27023953-C74A5F87-5284-447A-A2C9-0535BCF4E8A5Q27303708-9F0B97D8-58D7-48DE-8032-7B2215EA90DEQ27331411-3B51E4B3-D3A7-4E0E-8039-FB614C96C0C6Q28084450-E947644B-227A-433C-8447-906A99160A08Q28259238-213D3A13-6DD7-4558-B227-B57FA4AEB660Q28275105-4174C7FB-359B-487B-B892-DE39149187C2Q28535309-BF7882A2-EC4C-44E2-AFAC-89EB8C92151FQ29976920-99D5456F-92E9-482F-BA47-AEECAB55E638Q30276270-64090BE1-D58F-449B-BB8F-7A5C8EA1515EQ30278005-14AC6B27-EC3F-4673-A37C-70AF8547EF92Q30830179-1803786E-5125-4944-A76F-0395988F996BQ33555571-A3B48472-3FBB-4144-AEF1-248324C5A578Q33782706-3891C086-B22E-41EE-B382-199F6E0C42ACQ34110227-CE308C57-9B12-4720-A826-32805070E78EQ34147513-078C6220-AB75-431A-A665-C336B4987F01Q34193337-5A68D8C6-BF3A-4A56-AD5D-B6BC5E0BC0CFQ34209319-900D4655-A5E3-4129-AF43-4AA1F2B5750EQ34299304-52DA2C23-3396-4B89-83A8-935807CCAD36Q34375724-56169AE9-91C9-416F-92AB-2581B6A28412Q34518100-ECADB115-156D-40EB-B8DD-3A7B822226FFQ34722403-59116EA4-FBE9-478F-9910-7752E8570714Q34912085-1406FB06-1065-4F1F-B7E5-A3BA175ED5D8Q35064112-459BB39D-8401-4ACC-9C98-A5E625826B3CQ35071802-149F610A-2EB0-4D96-8663-EC4EEEF3D225Q35105958-122544F2-4C65-4F6C-A307-C5FBE8290671Q35127516-56363E66-E898-474D-9485-0E932A267721Q35185043-80ACA631-F8E6-47F0-BFE8-324522712701Q35189286-A1D99284-3738-4D5C-852C-144FD6E0E561Q35195013-610AEFBC-4E91-44E3-9B76-A6E21EA1D3ABQ35581445-EEA7B7E8-2A55-4CCA-A950-371CFE881B9BQ35592052-D6F96914-BEDD-47D0-BBF0-974BAF03113BQ35641883-B3226EE9-E5C7-46E4-8246-CE74703D0676Q35674780-226098AD-7D85-452F-88A2-55EEE12CF93AQ35711431-424999BD-9AEB-4FB0-9D71-4AD9636D3CD0
P2860
Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective targeting of perivas ...... n cerebral amyloid angiopathy.
@en
Selective targeting of perivas ...... n cerebral amyloid angiopathy.
@nl
type
label
Selective targeting of perivas ...... n cerebral amyloid angiopathy.
@en
Selective targeting of perivas ...... n cerebral amyloid angiopathy.
@nl
prefLabel
Selective targeting of perivas ...... n cerebral amyloid angiopathy.
@en
Selective targeting of perivas ...... n cerebral amyloid angiopathy.
@nl
P2860
P356
P1476
Selective targeting of perivas ...... in cerebral amyloid angiopathy
@en
P2093
Joanne McLaurin
P2860
P304
P356
10.1073/PNAS.0805453106
P407
P577
2009-01-21T00:00:00Z